LICENSE AGREEMENTLicense Agreement • July 17th, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 17th, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • July 17th, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 17th, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • July 17th, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 17th, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • June 23rd, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 23rd, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • June 23rd, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 23rd, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • June 23rd, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 23rd, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • May 14th, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 14th, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • May 14th, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 14th, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).
LICENSE AGREEMENTLicense Agreement • May 14th, 2014 • Immune Design Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 14th, 2014 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of the 15th day of October, 2010 (the “Agreement”) is made between Immune Design Corp., a Delaware corporation having a place of business at 1124 Columbia Street, Suite 700, Seattle, Washington 98104 (“IDC’) and MedImmune, LLC, a Delaware limited liability company having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”).